Mersana Therapeutics Publishes Review Article Detailing Advantages Of Its Lead Cancer Compound In Journal Of Advanced Drug Delivery Reviews
CAMBRIDGE, Massachusetts, November 12 /PRNewswire/ -- Mersana Therapeutics, a platform-based cancer therapeutics company, announced today that a review of the Company's lead compound, XMT-1001, will…